The global GLP-1 RA market is growing at 9.6 percent per annum, and is likely to increase from US$ 22.4 billion in 2022 to US$ 55.8 billion by 2032
Some third-party sources reference monthly billing, but the official site didn't clearly state that cadence in plain text
This combination data is largely preclinical and short-term and has not been validated in large human trials
For these reasons, comparing rates of hypoglycemia in clinical trials for TOUJEO with the incidence of hypoglycemia for other products may be misleading and also may not be representative of hypoglycemia rates that will occur in clinical practice
But you may just need this as a jumping-off point. According to the Gallup National Health and Well-Being Index, the obesity rate for Americans fell to 36.4% in 2026
Always consult a healthcare professional if pregnant, nursing, or under medical supervision